NCT06481488View on ClinicalTrials.gov

A Study of E2086 in Healthy Adult Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

June 25, 2024

Primary Completion Date

December 13, 2024

Study Completion Date

December 13, 2024

Conditions
Healthy Volunteers
Interventions
DRUG

E2086

E2086 tablets.

DRUG

Placebo

E2086 matched placebo tablets.

Trial Locations (1)

91206

Parexel International, Glendale

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT06481488 - A Study of E2086 in Healthy Adult Participants | Biotech Hunter | Biotech Hunter